NasdaqCM - Delayed Quote • USD
Capricor Therapeutics, Inc. (CAPR)
As of 9:49 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
25,178.07
25,178.07
2,551.47
244.90
310.25
Operating Expense
49,255.93
49,255.93
32,248.85
21,183.34
14,000.22
Operating Income
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Other Income Expense
1,790.32
1,790.32
677.85
915.92
32.94
Pretax Income
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Net Income Common Stockholders
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Diluted NI Available to Com Stockholders
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Basic EPS
-0.83
-0.83
-1.18
-0.87
-0.88
Diluted EPS
-0.83
-0.83
-1.18
-0.87
-0.88
Basic Average Shares
26,778.36
26,778.36
24,552.69
23,089.32
15,571.06
Diluted Average Shares
26,778.36
26,778.36
24,552.69
23,089.32
15,571.06
Total Operating Income as Reported
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Total Expenses
49,255.93
49,255.93
32,248.85
21,183.34
14,000.22
Net Income from Continuing & Discontinued Operation
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Normalized Income
-24,010.20
-24,010.20
-29,506.80
-20,390.24
-13,689.97
EBIT
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
EBITDA
-23,008.98
-23,008.98
-29,164.25
-20,692.75
-13,546.08
Reconciled Depreciation
1,068.88
1,068.88
533.13
245.70
143.89
Net Income from Continuing Operation Net Minority Interest
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Total Unusual Items Excluding Goodwill
1,722.66
1,722.66
487.27
367.72
32.94
Total Unusual Items
1,722.66
1,722.66
487.27
367.72
32.94
Normalized EBITDA
-24,731.64
-24,731.64
-29,651.52
-21,060.46
-13,579.02
12/31/2020 - 2/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACXP Acurx Pharmaceuticals, Inc.
2.0071
-0.64%
HOOK HOOKIPA Pharma Inc.
0.7801
-3.17%
NGENF NervGen Pharma Corp.
1.5000
0.00%
SLDB Solid Biosciences Inc.
8.52
-0.23%
ADTX Aditxt, Inc.
2.5800
+1.98%
ANL Adlai Nortye Ltd.
12.94
-3.86%
CYCC Cyclacel Pharmaceuticals, Inc.
1.4801
-7.36%
MDNAF Medicenna Therapeutics Corp.
1.5925
+13.94%
TARA Protara Therapeutics, Inc.
2.9663
-2.77%
INMB INmune Bio, Inc.
11.02
+1.66%